Literature DB >> 18819774

Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression.

Daniel F Gros1, Martin M Antony, Randi E McCabe, Richard P Swinson.   

Abstract

High rates of irritable bowel syndrome (IBS) symptoms have been reported in individuals diagnosed with anxiety and depressive disorders. However, most studies have investigated these relations in a single disorder, rather than a heterogeneous group of patients, thereby not allowing for comparisons across anxiety disorders and depression, or for considering the effects of comorbidity. Thus, the present study investigated the symptoms of IBS in a diverse group of patients (N=357) by administering questionnaires and a diagnostic interview. A high frequency of IBS symptoms was found in patients with panic disorder, generalized anxiety disorder, and major depressive disorder. However, the frequency of IBS symptoms in patients with social anxiety disorder, specific phobia, and obsessive-compulsive disorder was comparable to rates found in community samples. In addition, anxiety sensitivity and illness attitudes and intrusiveness were predictive of elevated IBS symptomatology. Together, these findings emphasize the role physiological symptoms of anxiety and worry in the co-occurrence of the anxiety disorders and IBS.

Entities:  

Mesh:

Year:  2008        PMID: 18819774     DOI: 10.1016/j.janxdis.2008.08.004

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  47 in total

1.  Prevalence and risk factors of irritable bowel syndrome in healthy screenee undergoing colonoscopy and laboratory tests.

Authors:  Su Youn Nam; Byung Chang Kim; Kum Hei Ryu; Bum Joon Park
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

2.  Relationship between cognitive factors and anxiety in individuals with irritable bowel syndrome.

Authors:  Nagisa Sugaya; Shinobu Nomura; Hironori Shimada
Journal:  Int J Behav Med       Date:  2012-09

Review 3.  Contextual conditioning in rats as an animal model for generalized anxiety disorder.

Authors:  Laura Luyten; Debora Vansteenwegen; Kris van Kuyck; Loes Gabriëls; Bart Nuttin
Journal:  Cogn Affect Behav Neurosci       Date:  2011-06       Impact factor: 3.282

4.  Identification and validation of urinary metabolite biomarkers for major depressive disorder.

Authors:  Peng Zheng; Ying Wang; Liang Chen; Deyu Yang; Huaqing Meng; Dezhi Zhou; Jiaju Zhong; Yang Lei; N D Melgiri; Peng Xie
Journal:  Mol Cell Proteomics       Date:  2012-10-30       Impact factor: 5.911

5.  The spectrum of functional gastrointestinal disorders in a tertiary referral clinic in Ireland.

Authors:  K Walsh; S R McWilliams; M M Maher; E M Quigley
Journal:  Ir J Med Sci       Date:  2011-09-24       Impact factor: 1.568

6.  The severity of psychiatric disorders.

Authors:  Mark Zimmerman; Theresa A Morgan; Kasey Stanton
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

7.  Trauma history and risk of the irritable bowel syndrome in women veterans.

Authors:  D L White; L S Savas; K Daci; R Elserag; D P Graham; S J Fitzgerald; S L Smith; G Tan; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2010-06-04       Impact factor: 8.171

Review 8.  What goes around comes around: novel pharmacological targets in the gut-brain axis.

Authors:  Camila González-Arancibia; Jorge Escobar-Luna; Camila Barrera-Bugueño; Camilo Díaz-Zepeda; María P González-Toro; Loreto Olavarría-Ramírez; Francesca Zanelli-Massai; Martin Gotteland; Javier A Bravo; Marcela Julio-Pieper
Journal:  Therap Adv Gastroenterol       Date:  2016-02-17       Impact factor: 4.409

Review 9.  Personality traits and emotional patterns in irritable bowel syndrome.

Authors:  Maria Rosaria A Muscatello; Antonio Bruno; Carmela Mento; Gianluca Pandolfo; Rocco A Zoccali
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

10.  Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes.

Authors:  Ami D Sperber; Roy Dekel
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.